4.4 Article

New Geldanamycin Analogs from Streptomyces hygroscopicus

Journal

JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY
Volume 22, Issue 11, Pages 1478-1481

Publisher

KOREAN SOC MICROBIOLOGY & BIOTECHNOLOGY
DOI: 10.4014/jmb.1206.06026

Keywords

Geldanamycin; natural products; biosynthetic shunt product

Funding

  1. 21C Frontier MGAC
  2. Global R&D Center Program
  3. Global Frontier Project (ISBC) [2011-0031947]
  4. NRF
  5. Next-Generation BioGreen 21 Program (SSAC) [PJ007999]
  6. RDA, Republic of Korea

Ask authors/readers for more resources

Geldanamycin (GM) and its analogs are important anticancer agents that inhibit heat shock protein (Hsp) 90, which is a major chaperone protein in cancer cells. Accordingly, based on interest in obtaining novel natural GM derivatives, the potential of Streptomyces hygroscopicus JCM4427, a GM producer, was explored for novel natural GM derivative(s), resulting in the discovery of new GM analogs as a biosynthetic shunt product and intermediates from its fermentation broth. In this study, the fermentation, isolation, structure determination, and biological activity of the compounds, two new tetracyclic thiazinogeldanamycin (1) and 19-hydroxy-4,5-dihydrogeldanamycin (3), together with the three known 4,5-dihydrothiazinogeldanamycin (2), reblastatin (4), and 17-demethoxy-reblastatin (5), are described.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available